ECM
Endurant Capital Management’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-155,793
| Closed | -$10.1M | – | 62 |
|
2019
Q1 | $10.1M | Buy |
+155,793
| New | +$10.1M | 4% | 6 |
|
2018
Q4 | – | Sell |
-10,315
| Closed | -$796K | – | 62 |
|
2018
Q3 | $796K | Sell |
10,315
-72,548
| -88% | -$5.6M | 0.35% | 52 |
|
2018
Q2 | $5.87M | Buy |
82,863
+35,663
| +76% | +$2.53M | 2.55% | 14 |
|
2018
Q1 | $3.56M | Buy |
+47,200
| New | +$3.56M | 1.33% | 25 |
|
2017
Q4 | – | Sell |
-27,357
| Closed | -$2.22M | – | 80 |
|
2017
Q3 | $2.22M | Sell |
27,357
-72,543
| -73% | -$5.88M | 0.67% | 52 |
|
2017
Q2 | $7.07M | Buy |
99,900
+77,900
| +354% | +$5.51M | 2% | 22 |
|
2017
Q1 | $1.49M | Buy |
+22,000
| New | +$1.49M | 0.48% | 55 |
|
2016
Q4 | – | Sell |
-20,810
| Closed | -$1.65M | – | 80 |
|
2016
Q3 | $1.65M | Sell |
20,810
-7,000
| -25% | -$554K | 0.61% | 38 |
|
2016
Q2 | $2.32M | Sell |
27,810
-40,000
| -59% | -$3.34M | 0.78% | 36 |
|
2016
Q1 | $6.23M | Buy |
67,810
+25,400
| +60% | +$2.33M | 2.02% | 22 |
|
2015
Q4 | $4.29M | Buy |
42,410
+11,410
| +37% | +$1.15M | 1.43% | 26 |
|
2015
Q3 | $3.04M | Sell |
31,000
-23,800
| -43% | -$2.34M | 1.02% | 37 |
|
2015
Q2 | $6.42M | Buy |
54,800
+21,700
| +66% | +$2.54M | 1.89% | 15 |
|
2015
Q1 | $3.25M | Buy |
33,100
+26,500
| +402% | +$2.6M | 1.07% | 35 |
|
2014
Q4 | $622K | Buy |
+6,600
| New | +$622K | 0.24% | 76 |
|